J&J, another vaccine maker, said it is "closely monitoring newly emerging COVID-19 virus strains with variations in the [virus’s] spike protein and are already testing the effectiveness of our vaccine against the new and rapidly spreading variant first detected in southern Africa.
WHO: Mutation in South Africa, 'omicron,' is a variant of concern
→
